Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Chan Lin

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|November 18, 2006
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancerPeng-Chan Lin, Wei-Shone Chen, Ta-Chung Chao, et al.
International Journal of Hematology|May 26, 2005
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patientsPeng-Chan Lin, Say-Bee Poh, Ming-Yang Lee, et al.
Scientific Reports|July 18, 2020
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerPeng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transitionYi-Ting Huang, Ya-Ting Hsu, Pei-Ying Wu, et al.
Science Translational Medicine|February 18, 2026
<i>BDNF</i> Val<sup>66</sup>Met protects oxaliplatin-induced peripheral neuropathy in patients with colorectal cancerLi-Hsien Chen, Peng-Chan Lin, Yu-Min Yeh, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal CancerRen-Hao Chan, Po-Chuan Chen, Yu-Min Yeh, et al.
BMC Cancer|March 3, 2021
Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapyPeng-Chan Lin, Yu-Min Yeh, Ren-Hao Chan, et al.
Journal of the Chinese Medical Association : JCMA|August 15, 2006
Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancerPeng-Chan Lin, Wei-Shu Wang, Muh-Hwa Yang, et al.
Disease Markers|April 8, 2022
The Value of Artificial Intelligence-Assisted Imaging in Identifying Diagnostic Markers of Sarcopenia in Patients with CancerYing-Tzu Huang, Yi-Shan Tsai, Peng-Chan Lin, et al.
Cancers|August 27, 2021
<i>MET</i> Mutation Is a Potential Therapeutic Target for Advanced Endometrial CancerYu-Min Yeh, Pei-Ying Wu, Peng-Chan Lin, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|November 18, 2006
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancerPeng-Chan Lin, Wei-Shone Chen, Ta-Chung Chao, et al.
International Journal of Hematology|May 26, 2005
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patientsPeng-Chan Lin, Say-Bee Poh, Ming-Yang Lee, et al.
Scientific Reports|July 18, 2020
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancerPeng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transitionYi-Ting Huang, Ya-Ting Hsu, Pei-Ying Wu, et al.
Science Translational Medicine|February 18, 2026
<i>BDNF</i> Val<sup>66</sup>Met protects oxaliplatin-induced peripheral neuropathy in patients with colorectal cancerLi-Hsien Chen, Peng-Chan Lin, Yu-Min Yeh, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal CancerRen-Hao Chan, Po-Chuan Chen, Yu-Min Yeh, et al.
BMC Cancer|March 3, 2021
Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapyPeng-Chan Lin, Yu-Min Yeh, Ren-Hao Chan, et al.
Journal of the Chinese Medical Association : JCMA|August 15, 2006
Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancerPeng-Chan Lin, Wei-Shu Wang, Muh-Hwa Yang, et al.
Disease Markers|April 8, 2022
The Value of Artificial Intelligence-Assisted Imaging in Identifying Diagnostic Markers of Sarcopenia in Patients with CancerYing-Tzu Huang, Yi-Shan Tsai, Peng-Chan Lin, et al.
Cancers|August 27, 2021
<i>MET</i> Mutation Is a Potential Therapeutic Target for Advanced Endometrial CancerYu-Min Yeh, Pei-Ying Wu, Peng-Chan Lin, et al.
Pageof 9